FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022413799> ?p ?o ?g. }

• W2022413799 endingPage "1314" @default.
• W2022413799 startingPage "1305" @default.
• W2022413799 abstract "Despite recent advances in the first-line treatment of multiple myeloma, almost all patients eventually experience relapse with drug-resistant disease. New therapeutic modalities are needed, and to this end, SNS01, a therapeutic nanoparticle, is being investigated for treatment of multiple myeloma. The antitumoral activity of SNS01 is based upon modulation of eukaryotic translation initiation factor 5A (eIF5A), a highly conserved protein that is involved in many cellular processes including proliferation, apoptosis, differentiation and inflammation. eIF5A is regulated by post-translational hypusine modification, and overexpression of hypusination-resistant mutants of eIF5A induces apoptosis in many types of cancer cells. SNS01 is a polyethylenimine (PEI)-based nanoparticle that contains both a B-cell-specific expression plasmid expressing a non-hypusinable mutant of eIF5A and a small interfering RNA (siRNA) which depletes endogenous hypusinated eIF5A. Reducing hypusine-modified eIF5A levels was found to inhibit phosphorylation and activity of ERK MAPK and nuclear factor-κB (NF-κB), and thus sensitize myeloma cells to apoptosis resulting from transfection of a plasmid expressing eIF5AK50R. SNS01 exhibited significant antitumoral activity in both KAS-6/1 (95% inhibition; P < 0.05) and RPMI 8226 (59% inhibition; P < 0.05) multiple myeloma xenograft models following systemic administration. These results highlight the potential of using this approach as a new therapeutic strategy for multiple myeloma." @default.
• W2022413799 created "2016-06-24" @default.
• W2022413799 creator A5011388829 @default.
• W2022413799 creator A5013579372 @default.
• W2022413799 creator A5013801367 @default.
• W2022413799 creator A5028054372 @default.
• W2022413799 creator A5029312878 @default.
• W2022413799 creator A5036150860 @default.
• W2022413799 creator A5044273512 @default.
• W2022413799 creator A5052814363 @default.
• W2022413799 creator A5054351395 @default.
• W2022413799 creator A5072479467 @default.
• W2022413799 date "2012-07-01" @default.
• W2022413799 modified "2023-10-15" @default.
• W2022413799 title "Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma" @default.
• W2022413799 cites W1517472403 @default.
• W2022413799 cites W1534011301 @default.
• W2022413799 cites W1544068656 @default.
• W2022413799 cites W1549679997 @default.
• W2022413799 cites W1555980866 @default.
• W2022413799 cites W1580850944 @default.
• W2022413799 cites W1883440514 @default.
• W2022413799 cites W1967835933 @default.
• W2022413799 cites W1969078685 @default.
• W2022413799 cites W1977707794 @default.
• W2022413799 cites W1983788160 @default.
• W2022413799 cites W1989213147 @default.
• W2022413799 cites W1992478143 @default.
• W2022413799 cites W1993541870 @default.
• W2022413799 cites W1996217096 @default.
• W2022413799 cites W2005747790 @default.
• W2022413799 cites W2009588836 @default.
• W2022413799 cites W2016071270 @default.
• W2022413799 cites W2021693767 @default.
• W2022413799 cites W2023642475 @default.
• W2022413799 cites W2030790110 @default.
• W2022413799 cites W2034029588 @default.
• W2022413799 cites W2037400766 @default.
• W2022413799 cites W2038511535 @default.
• W2022413799 cites W2041395895 @default.
• W2022413799 cites W2041593752 @default.
• W2022413799 cites W2044613677 @default.
• W2022413799 cites W2049093430 @default.
• W2022413799 cites W2056171616 @default.
• W2022413799 cites W2056875662 @default.
• W2022413799 cites W2067203011 @default.
• W2022413799 cites W2080480715 @default.
• W2022413799 cites W2083119952 @default.
• W2022413799 cites W2083609595 @default.
• W2022413799 cites W2083741449 @default.
• W2022413799 cites W2086151489 @default.
• W2022413799 cites W2090850633 @default.
• W2022413799 cites W2092868756 @default.
• W2022413799 cites W2094330276 @default.
• W2022413799 cites W2100177180 @default.
• W2022413799 cites W2101904615 @default.
• W2022413799 cites W2116657176 @default.
• W2022413799 cites W2121106253 @default.
• W2022413799 cites W2133234260 @default.
• W2022413799 cites W2134235310 @default.
• W2022413799 cites W2152687551 @default.
• W2022413799 doi "https://doi.org/10.1038/mt.2012.94" @default.
• W2022413799 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3392975" @default.
• W2022413799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22588272" @default.
• W2022413799 hasPublicationYear "2012" @default.
• W2022413799 type Work @default.
• W2022413799 sameAs 2022413799 @default.
• W2022413799 citedByCount "30" @default.
• W2022413799 countsByYear W20224137992013 @default.
• W2022413799 countsByYear W20224137992014 @default.
• W2022413799 countsByYear W20224137992015 @default.
• W2022413799 countsByYear W20224137992016 @default.
• W2022413799 countsByYear W20224137992017 @default.
• W2022413799 countsByYear W20224137992018 @default.
• W2022413799 countsByYear W20224137992019 @default.
• W2022413799 countsByYear W20224137992020 @default.
• W2022413799 countsByYear W20224137992022 @default.
• W2022413799 countsByYear W20224137992023 @default.
• W2022413799 crossrefType "journal-article" @default.
• W2022413799 hasAuthorship W2022413799A5011388829 @default.
• W2022413799 hasAuthorship W2022413799A5013579372 @default.
• W2022413799 hasAuthorship W2022413799A5013801367 @default.
• W2022413799 hasAuthorship W2022413799A5028054372 @default.
• W2022413799 hasAuthorship W2022413799A5029312878 @default.
• W2022413799 hasAuthorship W2022413799A5036150860 @default.
• W2022413799 hasAuthorship W2022413799A5044273512 @default.
• W2022413799 hasAuthorship W2022413799A5052814363 @default.
• W2022413799 hasAuthorship W2022413799A5054351395 @default.
• W2022413799 hasAuthorship W2022413799A5072479467 @default.
• W2022413799 hasBestOaLocation W20224137991 @default.
• W2022413799 hasConcept C104317684 @default.
• W2022413799 hasConcept C105580179 @default.
• W2022413799 hasConcept C11960822 @default.
• W2022413799 hasConcept C149364088 @default.
• W2022413799 hasConcept C153911025 @default.
• W2022413799 hasConcept C166703698 @default.
• W2022413799 hasConcept C185592680 @default.
• W2022413799 hasConcept C190283241 @default.

• next